Immunocore Holdings plc (IMCR)
USD 24.53
(-6.66%)
USD 24.53
(-6.66%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 228.15 Million USD | 45.54% |
| 2022 | 156.76 Million GBP | 20.38% |
| 2021 | 130.22 Million GBP | -8.19% |
| 2020 | 141.84 Million GBP | -16.99% |
| 2019 | 170.87 Million GBP | 22.76% |
| 2018 | 139.19 Million GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 664.22 Million USD | 4.69% |
| 2024 Q1 | 634.45 Million USD | 178.08% |
| 2023 Q3 | 209.9 Million USD | 1.64% |
| 2023 Q2 | 206.51 Million USD | 32.01% |
| 2023 FY | 228.15 Million USD | 45.54% |
| 2023 Q1 | 156.44 Million USD | -0.2% |
| 2023 Q4 | 228.15 Million USD | 8.7% |
| 2022 Q3 | 149.85 Million GBP | 14.47% |
| 2022 Q2 | 130.91 Million GBP | 10.26% |
| 2022 FY | 156.76 Million GBP | 20.38% |
| 2022 Q1 | 118.73 Million GBP | -8.82% |
| 2022 Q4 | 156.76 Million GBP | 4.61% |
| 2021 Q1 | 135.35 Million GBP | -4.58% |
| 2021 FY | 130.22 Million GBP | -8.19% |
| 2021 Q4 | 130.22 Million GBP | 1.07% |
| 2021 Q3 | 128.85 Million GBP | -1.54% |
| 2021 Q2 | 130.87 Million GBP | -3.31% |
| 2020 Q3 | 115.29 Million GBP | 0.0% |
| 2020 FY | 141.84 Million GBP | -16.99% |
| 2020 Q4 | 141.84 Million GBP | 23.03% |
| 2019 FY | 170.87 Million GBP | 22.76% |
| 2019 Q4 | 170.87 Million GBP | 0.0% |
| 2018 FY | 139.19 Million GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 272.28 Million USD | 16.207% |
| Jaguar Health, Inc. | 45.86 Million USD | -397.445% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -503.401% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2234.336% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 94.367% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -74.557% |
| ContextLogic Inc. | 206 Million USD | -10.756% |
| MiMedx Group, Inc. | 96.33 Million USD | -136.85% |
| MEI Pharma, Inc. | 8.35 Million USD | -2630.796% |
| AlloVir, Inc. | 45.01 Million USD | -406.849% |
| Novavax, Inc. | 2.57 Billion USD | 91.13% |
| Aptorum Group Limited | 5.25 Million USD | -4240.296% |
| Ardelyx, Inc. | 130.76 Million USD | -74.482% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 52.307% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -1784.871% |
| Vaxcyte, Inc. | 167.44 Million USD | -36.255% |
| Precigen, Inc. | 41.64 Million USD | -447.877% |
| Pharming Group N.V. | 244.07 Million USD | 6.521% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 53.112% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -1813.756% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -56.413% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -78.54% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -6365.438% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3353.131% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3353.131% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1.669% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -176.78% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3334.563% |
| Acelyrin, Inc. | 86.35 Million USD | -164.215% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1486.745% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2306.984% |
| Senti Biosciences, Inc. | 52.57 Million USD | -334.0% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -231.736% |
| AbCellera Biologics Inc. | 335.77 Million USD | 32.051% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -11564.519% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -75.223% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -0.585% |
| Chimerix, Inc. | 19.74 Million USD | -1055.523% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2335.764% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -686.345% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -548.598% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -494.58% |
| Elevation Oncology, Inc. | 34.28 Million USD | -565.533% |
| Alkermes plc | 933.53 Million USD | 75.56% |
| Fortress Biotech, Inc. | 165.93 Million USD | -37.495% |
| Fortress Biotech, Inc. | 165.93 Million USD | -37.495% |
| Agenus Inc. | 462.29 Million USD | 50.647% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -219.191% |
| Dyadic International, Inc. | 2.34 Million USD | -9647.63% |
| ImmuCell Corporation | 18.81 Million USD | -1112.637% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1302.927% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -708.326% |
| Lantern Pharma Inc. | 2.73 Million USD | -8227.901% |
| Immix Biopharma, Inc. | 3.72 Million USD | -6030.341% |
| Incyte Corporation | 1.59 Billion USD | 85.671% |
| IO Biotech, Inc. | 17.55 Million USD | -1199.601% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -532.753% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -6365.735% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -388.153% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -50.587% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -9231.616% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -729.334% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | 3.0% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 53.862% |
| NextCure, Inc. | 14.99 Million USD | -1421.358% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -5544.681% |
| Onconetix, Inc. | 23.18 Million USD | -884.25% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3317.074% |
| Opthea Limited | 264.6 Million USD | 13.773% |
| PDS Biotechnology Corporation | 33.25 Million USD | -586.001% |
| PureTech Health plc | 125.58 Million USD | -81.679% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -375.111% |
| Seer, Inc. | 39.36 Million USD | -479.596% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -17460.868% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -356.956% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -16983.27% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2449.251% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -0.313% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 34.358% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -75.052% |
| ChromaDex Corporation | 26.5 Million USD | -760.714% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -1990.508% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -214.41% |
| CRISPR Therapeutics AG | 346.76 Million USD | 34.204% |
| Precision BioSciences, Inc. | 140.92 Million USD | -61.906% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -65.572% |
| Innoviva, Inc. | 568.55 Million USD | 59.87% |
| Summit Therapeutics Inc. | 125.25 Million USD | -82.152% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -268.985% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -737.954% |
| ESSA Pharma Inc. | 3.49 Million USD | -6427.993% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3205.644% |
| GT Biopharma, Inc. | 6.63 Million USD | -3339.741% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | 13.704% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -171.533% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -739.773% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -6972.971% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -209.295% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1343.243% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -1966.707% |
| Soligenix, Inc. | 7.27 Million USD | -3036.234% |
| Century Therapeutics, Inc. | 175.94 Million USD | -29.679% |
| Kura Oncology, Inc. | 51.66 Million USD | -341.636% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -88.122% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -5420.397% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -3349.698% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | 9.675% |
| Autolus Therapeutics plc | 263.9 Million USD | 13.546% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2076.665% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -156.758% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -386.488% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 35.34% |
| GRI Bio, Inc. | 2.69 Million USD | -8359.696% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -28082.093% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -633.839% |
| IGM Biosciences, Inc. | 220.17 Million USD | -3.625% |
| INmune Bio, Inc. | 18.86 Million USD | -1109.617% |
| Heron Therapeutics, Inc. | 256.47 Million USD | 11.042% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -756.391% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -8293.08% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -6855.473% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -290.314% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -137.272% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 13.816% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 72.278% |
| Verastem, Inc. | 71.18 Million USD | -220.514% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -363.962% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -491.42% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -366.276% |
| Histogen Inc. | 5.69 Million USD | -3904.88% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -5102.429% |
| Surrozen, Inc. | 8.14 Million USD | -2701.203% |
| Organovo Holdings, Inc. | 2.74 Million USD | -8202.693% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -72594.658% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -305.759% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1281.771% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -346.467% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -27492.804% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -80.042% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2009.919% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -51.209% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -8650.587% |
| Apollomics, Inc. | 14.15 Million USD | -1512.082% |
| Amarin Corporation plc | 279.58 Million USD | 18.395% |
| Mesoblast Limited | 188.79 Million USD | -20.848% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1512.652% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -26.202% |
| Synaptogenix, Inc. | 5.52 Million USD | -4026.219% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3331.98% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -34.125% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2566.272% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -12882.753% |
| Exelixis, Inc. | 678.44 Million USD | 66.37% |
| Better Therapeutics, Inc. | 23.84 Million USD | -856.958% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -39.082% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 61.603% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2036.27% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -13952.461% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -486.118% |
| Gritstone bio, Inc. | 125.91 Million USD | -81.194% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1454.633% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -4383.685% |
| Avid Bioservices, Inc. | 275.66 Million USD | 17.234% |
| Insmed Incorporated | 1.66 Billion USD | 86.27% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -2865.392% |
| MediWound Ltd. | 27.18 Million USD | -739.217% |
| OmniAb, Inc. | 87.4 Million USD | -161.05% |
| Alector, Inc. | 487.66 Million USD | 53.215% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 43.449% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1138.307% |
| Zai Lab Limited | 240.17 Million USD | 5.004% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 63.788% |
| Aura Biosciences, Inc. | 29.22 Million USD | -680.641% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -139.972% |
| Immunic, Inc. | 25.36 Million USD | -799.393% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -229.537% |
| Veracyte, Inc. | 93.71 Million USD | -143.449% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -8619.393% |
| FibroGen, Inc. | 585.72 Million USD | 61.047% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1212.535% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -34835.903% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -3934.297% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 97.02% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -2683.093% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -171.546% |
| TG Therapeutics, Inc. | 169.08 Million USD | -34.937% |
| Galecto, Inc. | 5.89 Million USD | -3769.708% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -2654.201% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 91.286% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -691.611% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1707.765% |
| XBiotech Inc. | 8.39 Million USD | -2617.137% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1454.633% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -329.03% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 37.165% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -748.676% |
| Theravance Biopharma, Inc. | 169 Million USD | -35.002% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 81.231% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 54.407% |
| Vaxxinity, Inc. | 30.94 Million USD | -637.325% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 76.539% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -3683.02% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 69.384% |
| NexImmune, Inc. | 5.08 Million USD | -4387.561% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -61332.872% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -7320.139% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.79% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -4326.788% |
| Scopus BioPharma Inc. | 7.45 Million USD | -2960.702% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -767.719% |
| Ainos, Inc. | 7.39 Million USD | -2985.625% |
| Pluri Inc. | 34.11 Million USD | -568.85% |
| Prothena Corporation plc | 135.01 Million USD | -68.985% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | 6.148% |
| Celularity Inc. | 102.92 Million USD | -121.665% |
| Rallybio Corporation | 9.43 Million USD | -2317.953% |
| Cue Biopharma, Inc. | 24.44 Million USD | -833.352% |
| MeiraGTx Holdings plc | 319.99 Million USD | 28.699% |
| Omeros Corporation | 403.25 Million USD | 43.42% |
| Humacyte, Inc. | 114.67 Million USD | -98.957% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -4580.164% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -197.313% |
| Blueprint Medicines Corporation | 918.64 Million USD | 75.164% |
| CalciMedica, Inc. | 4.02 Million USD | -5564.3% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1207.346% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -48.017% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -165.866% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 17.868% |
| Pulmatrix, Inc. | 15.96 Million USD | -1329.293% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1346.51% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -827.245% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | 9.031% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -349.254% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 81.154% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -617.862% |
| Nutriband Inc. | 1.07 Million USD | -21046.907% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2045.754% |
| Vor Biopharma Inc. | 59.1 Million USD | -286.028% |
| Roivant Sciences Ltd. | 773.95 Million USD | 70.52% |
| Evogene Ltd. | 17.99 Million USD | -1168.249% |
| ProKidney Corp. | 29.21 Million USD | -680.935% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -216.979% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -32263.617% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 87.921% |
| CorMedix Inc. | 11.91 Million USD | -1814.474% |
| BioLineRx Ltd. | 50.7 Million USD | -349.998% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -52.656% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -157.978% |
| Atai Life Sciences N.V. | 49.16 Million USD | -364.094% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -632.395% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1170.226% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -83.059% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -3935.338% |
| MediciNova, Inc. | 3.89 Million USD | -5762.904% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1148.197% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -15067.649% |
| GeoVax Labs, Inc. | 3.51 Million USD | -6381.98% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 42.567% |
| Biomea Fusion, Inc. | 30.69 Million USD | -643.428% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 91.617% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1329.382% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -631.252% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -288.791% |
| Absci Corporation | 58.3 Million USD | -291.325% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1097.806% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -611.615% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -209.199% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -160.803% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -575.623% |
| Allakos Inc. | 74.79 Million USD | -205.053% |
| Imunon, Inc. | 8.53 Million USD | -2574.638% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -913.99% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -98.723% |
| BioAtla, Inc. | 48.98 Million USD | -365.762% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2036.27% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -8110.076% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -74.694% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1505.051% |
| XOMA Corporation | 145.58 Million USD | -56.723% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -577.731% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -231.823% |
| aTyr Pharma, Inc. | 31.59 Million USD | -622.088% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -269.05% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -407.412% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -371.381% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -7849.756% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -2696.733% |
| Akari Therapeutics, Plc | 4.58 Million USD | -4877.269% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1186.62% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 86.168% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -56387.616% |
| UroGen Pharma Ltd. | 243.52 Million USD | 6.309% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 28.942% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -8161.93% |
| Orgenesis Inc. | 35.53 Million USD | -542.066% |
| Entera Bio Ltd. | 1.37 Million USD | -16445.178% |
| GH Research PLC | 6.7 Million USD | -3304.835% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3255.265% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1111.93% |
| Xencor, Inc. | 283.55 Million USD | 19.538% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -7541.756% |
| Replimune Group, Inc. | 113.21 Million USD | -101.528% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -5972.675% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -120.379% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -56387.616% |
| Portage Biotech Inc. | 4.45 Million USD | -5027.146% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -15067.649% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -889.839% |
| OncoCyte Corporation | 49.29 Million USD | -362.814% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -5415.319% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -28509.728% |
| Purple Biotech Ltd. | 10 Million USD | -2180.44% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -3843.277% |
| scPharmaceuticals Inc. | 57.26 Million USD | -298.453% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -1741.763% |
| HilleVax, Inc. | 78.9 Million USD | -189.141% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -4417.98% |
| Tharimmune, Inc. | 1.81 Million USD | -12470.37% |
| Genprex, Inc. | 3.25 Million USD | -6911.168% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -741.322% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -4257.487% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -110656.311% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -63533.879% |
| OKYO Pharma Limited | 7.42 Million USD | -2974.555% |
| Savara Inc. | 37.19 Million USD | -513.46% |
| Curis, Inc. | 57.61 Million USD | -296.025% |
| Daré Bioscience, Inc. | 26.32 Million USD | -766.537% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -482.039% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -15700.416% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -995.912% |
| BeiGene, Ltd. | 2.23 Billion USD | 89.786% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -971.678% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | 13.049% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -972.473% |
| Erasca, Inc. | 78.61 Million USD | -190.237% |
| bluebird bio, Inc. | 424.62 Million USD | 46.268% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -34719.886% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 87.928% |
| DBV Technologies S.A. | 42.8 Million USD | -433.079% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -34719.886% |
| Moderna, Inc. | 4.57 Billion USD | 95.01% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3161.73% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -13677.657% |
| Molecular Templates, Inc. | 31.17 Million USD | -631.956% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1236.602% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 61.204% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -83.252% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -731.571% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -525.845% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -310.098% |
| MacroGenics, Inc. | 154.2 Million USD | -47.956% |
| RenovoRx, Inc. | 4.46 Million USD | -5008.777% |
| Adicet Bio, Inc. | 37.12 Million USD | -514.65% |
| Prime Medicine, Inc. | 60.78 Million USD | -275.383% |
| Aditxt, Inc. | 28.53 Million USD | -699.669% |
| Adagene Inc. | 45.16 Million USD | -405.117% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -126162.721% |
| Quantum-Si incorporated | 26.63 Million USD | -756.738% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 67.292% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -7399.183% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -98.466% |
| SciSparc Ltd. | 1.59 Million USD | -14204.577% |
| Vericel Corporation | 127.7 Million USD | -78.66% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -3999.952% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -167.295% |
| Generation Bio Co. | 171.63 Million USD | -32.936% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -1875.394% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -445.428% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | 9.711% |
| Invivyd, Inc. | 51.71 Million USD | -341.2% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -148.06% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -3407.29% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -202.212% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -22246.523% |
| 2seventy bio, Inc. | 310.12 Million USD | 26.431% |
| ADMA Biologics, Inc. | 193.97 Million USD | -17.622% |
| Clene Inc. | 38.95 Million USD | -485.756% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -531.442% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | 11.214% |
| GeoVax Labs, Inc. | 3.51 Million USD | -6381.98% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -19.917% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -1773.27% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -15.044% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -1770.945% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -374.233% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -331.782% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 38.311% |
| Evaxion Biotech A/S | 17.61 Million USD | -1195.066% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -41.776% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -48.942% |
| Trevena, Inc. | 48.26 Million USD | -372.749% |
| Surrozen, Inc. | 8.14 Million USD | -2701.203% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -956.532% |
| Cingulate Inc. | 10.36 Million USD | -2102.113% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -8196.655% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -511.815% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -6261.543% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1635.042% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 28.071% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -818.178% |
| Clearmind Medicine Inc. | 3.61 Million USD | -6220.152% |
| Kronos Bio, Inc. | 54.2 Million USD | -320.948% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -384.999% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -902.463% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1036.755% |
| Statera Biopharma, Inc. | 22.67 Million USD | -906.145% |
| ImmunityBio, Inc. | 1.09 Billion USD | 79.076% |
| Korro Bio, Inc. | 51.75 Million USD | -340.868% |
| Kineta, Inc. | 7.22 Million USD | -3059.208% |
| BioVie Inc. | 9.7 Million USD | -2251.628% |
| Codexis, Inc. | 49.94 Million USD | -356.809% |
| Celularity Inc. | 102.92 Million USD | -121.665% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -137.055% |
| Celcuity Inc. | 51.45 Million USD | -343.455% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -65995.587% |
| Cibus, Inc. | 206.11 Million USD | -10.693% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -437.158% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -766.236% |
| IN8bio, Inc. | 8.77 Million USD | -2500.98% |
| Kodiak Sciences Inc. | 213.59 Million USD | -6.82% |
| Annexon, Inc. | 47.11 Million USD | -384.227% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -154.808% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -136.747% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1566.725% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 91.236% |
| Eyenovia, Inc. | 19.78 Million USD | -1053.462% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -28.84% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -2870.421% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -846.753% |
| Arcellx, Inc. | 339.75 Million USD | 32.846% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -1817.616% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | 7.079% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2285.841% |
| Moolec Science SA | 13.94 Million USD | -1536.086% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -428.731% |
| Geron Corporation | 146.12 Million USD | -56.137% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -351.512% |
| Royalty Pharma plc | 6.29 Billion USD | 96.377% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -473.607% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -77397.741% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -9173.652% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -20.619% |
| Humacyte, Inc. | 114.67 Million USD | -98.957% |
| Structure Therapeutics Inc. | 29.05 Million USD | -685.37% |
| 89bio, Inc. | 59.96 Million USD | -280.498% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -762.177% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -18976.756% |
| Genelux Corporation | 8.42 Million USD | -2609.715% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3227.859% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -67.371% |
| Notable Labs, Ltd. | 4.42 Million USD | -5053.784% |
| Liquidia Corporation | 73.13 Million USD | -211.955% |
| Mustang Bio, Inc. | 17.61 Million USD | -1194.954% |
| Immunovant, Inc. | 48.95 Million USD | -366.057% |
| Quantum-Si incorporated | 26.63 Million USD | -756.738% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -494.425% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -7252.82% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -208.902% |
| Acasti Pharma Inc. | 11.55 Million USD | -1874.197% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -909.203% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -8293.08% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -518.7% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -16641.339% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -3642.749% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -818.695% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -884.118% |
| PepGen Inc. | 34.63 Million USD | -558.826% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -1778.771% |
| United Therapeutics Corporation | 1.18 Billion USD | 80.701% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3166.867% |
| Solid Biosciences Inc. | 38.45 Million USD | -493.265% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2566.272% |
| Immuneering Corporation | 12 Million USD | -1799.994% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -72594.658% |
| Silo Pharma, Inc. | 1.56 Million USD | -14439.117% |
| Belite Bio, Inc | 4.21 Million USD | -5318.143% |
| XOMA Corporation | 145.58 Million USD | -56.723% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -9296.952% |
| Bionomics Limited | 10.15 Million USD | -2145.932% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -961.644% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -895.758% |
| uniQure N.V. | 624.01 Million USD | 63.437% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1507.312% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -126162.721% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -34.065% |
| Forte Biosciences, Inc. | 3.66 Million USD | -6123.622% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -87456.748% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3281.621% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -2870.421% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1212.535% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2058.952% |
| Altimmune, Inc. | 16.54 Million USD | -1279.348% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 63.064% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -895.758% |
| Compugen Ltd. | 55.77 Million USD | -309.069% |
| Peak Bio, Inc. | 20.75 Million USD | -999.378% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -106.547% |
| Benitec Biopharma Inc. | 4.96 Million USD | -4498.106% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -44.547% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -203.507% |
| Zura Bio Limited | 21.29 Million USD | -971.567% |
| PolyPid Ltd. | 17.46 Million USD | -1206.148% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -102.989% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -203.507% |
| Instil Bio, Inc. | 99.8 Million USD | -128.613% |
| argenx SE | 444.95 Million USD | 48.723% |
| Immunome, Inc. | 28.65 Million USD | -696.141% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -2636.692% |
| Verona Pharma plc | 58.84 Million USD | -287.753% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1476.439% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1435.487% |
| CervoMed Inc. | 2.59 Million USD | -8689.686% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -4581.124% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1691.442% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2065.714% |
| Moolec Science SA | 13.94 Million USD | -1536.086% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -9635.763% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -310.391% |
| AnaptysBio, Inc. | 364.28 Million USD | 37.368% |
| Design Therapeutics, Inc. | 11.95 Million USD | -1808.314% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1698.786% |
| NeurAxis, Inc. | 1.91 Million USD | -11828.339% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -486.103% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1611.228% |
| Achilles Therapeutics plc | 19.08 Million USD | -1095.358% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1476.439% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4135.18% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -867.263% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -902.463% |
| Nutriband Inc. | 1.07 Million USD | -21046.907% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -645.663% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1472.311% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 43.142% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -602.608% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1648.458% |
| Palisade Bio, Inc. | 2.73 Million USD | -8229.974% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -4243.385% |
| Beam Therapeutics Inc. | 478.38 Million USD | 52.307% |
| Neurogene Inc. | 36.54 Million USD | -524.252% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 42.667% |
| AEON Biopharma, Inc. | 159.88 Million USD | -42.698% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -378.821% |
| Sesen Bio, Inc. | 30.98 Million USD | -636.374% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -778.849% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -2901.204% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -16.563% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -18.797% |
| Athira Pharma, Inc. | 30.05 Million USD | -659.084% |
| Vaccinex, Inc. | 5.94 Million USD | -3739.751% |
| HCW Biologics Inc. | 15.05 Million USD | -1415.804% |
| XOMA Corporation | 145.58 Million USD | -56.723% |
| Nektar Therapeutics | 267.04 Million USD | 14.562% |
| Arvinas, Inc. | 644.6 Million USD | 64.605% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1186.62% |
| Merus N.V. | 102.15 Million USD | -123.354% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -55.899% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -139.863% |
| Rezolute, Inc. | 11.73 Million USD | -1844.418% |
| Clene Inc. | 38.95 Million USD | -485.756% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -7912.91% |
| BeyondSpring Inc. | 48.26 Million USD | -372.68% |
| Synlogic, Inc. | 32.89 Million USD | -593.595% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1461.336% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -13863.158% |
| Peak Bio, Inc. | 20.75 Million USD | -999.378% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -259.536% |
| Krystal Biotech, Inc. | 39.71 Million USD | -474.503% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 39.423% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -129.146% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -52625.743% |
| MannKind Corporation | 721.36 Million USD | 68.371% |
| Ikena Oncology, Inc. | 22.33 Million USD | -921.527% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -10837.584% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -122.398% |
| Gossamer Bio, Inc. | 249.14 Million USD | 8.424% |
| CohBar, Inc. | 1.03 Million USD | -21973.298% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2034.512% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1097.806% |
| Legend Biotech Corporation | 589.93 Million USD | 61.325% |
| Mural Oncology plc | 37.92 Million USD | -501.556% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -72.018% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -9840.087% |
| Disc Medicine, Inc. | 22.87 Million USD | -897.412% |
| Champions Oncology, Inc. | 28.03 Million USD | -713.833% |
| REGENXBIO Inc. | 262.22 Million USD | 12.993% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -6691.726% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -1720.313% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1598.662% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -975.963% |
| Vaxart, Inc. | 34.02 Million USD | -570.56% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1019.01% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -699.66% |
| Cellectis S.A. | 249.57 Million USD | 8.581% |
| Longeveron Inc. | 5.33 Million USD | -4175.023% |
| Repare Therapeutics Inc. | 41.81 Million USD | -445.585% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 90.514% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -277.945% |
| Revolution Medicines, Inc. | 262.39 Million USD | 13.049% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -10728.571% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -2545.003% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -1833.379% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1524.71% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -10507.066% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 95.57% |
| Denali Therapeutics Inc. | 122.96 Million USD | -85.55% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -3999.952% |
| Veru Inc. | 32.81 Million USD | -595.334% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3221.561% |
| Cingulate Inc. | 10.36 Million USD | -2102.113% |
| Passage Bio, Inc. | 39.26 Million USD | -481.117% |
| Context Therapeutics Inc. | 4.19 Million USD | -5343.07% |
| Exicure, Inc. | 8.54 Million USD | -2568.827% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -673.207% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2075.834% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -935.153% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -39.986% |
| Nuvalent, Inc. | 31.82 Million USD | -616.959% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -3486.472% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -262.029% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1167.544% |
| OmniAb, Inc. | 87.4 Million USD | -161.05% |
| Anew Medical, Inc. | 8.24 Million USD | -2668.303% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -495.882% |
| Lipocine Inc. | 2.63 Million USD | -8569.839% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -768.445% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -467.388% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -756.391% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -164.826% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4124.366% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -175.73% |
| Ocugen, Inc. | 23.98 Million USD | -851.332% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -391.646% |
| Q32 Bio Inc. | 233.12 Million USD | 2.132% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2416.634% |
| Alumis Inc. Common Stock | 53.5 Million USD | -326.448% |
| Equillium, Inc. | 27.95 Million USD | -716.103% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -10.439% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -3954.942% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -3620.189% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -45.022% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -228.602% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2187.481% |
| Dominari Holdings Inc. | 4.63 Million USD | -4822.503% |
| Edesa Biotech, Inc. | 1.84 Million USD | -12288.869% |
| vTv Therapeutics Inc. | 29.56 Million USD | -671.664% |
| Bio-Techne Corporation | 744.34 Million USD | 69.348% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -80.936% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 33.763% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -462.312% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -687.92% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -147.031% |
| Nkarta, Inc. | 105.6 Million USD | -116.059% |
| BioCardia, Inc. | 4.59 Million USD | -4870.763% |
| Iterum Therapeutics plc | 32.66 Million USD | -598.543% |